top of page
About Us
Overview
Leadership
Our Board
Scientific Advisors
Collaborations
Our Technology
Overview
T-SIGn Platform
Unlocking Cell Therapy
Our Pipeline
Overview
Clinical Trials
Patients
Our News
Top News
News Archives
Media Enquiries
Publications
More
Use tab to navigate through the menu items.
Join Us
Contact Us
Our Board
Overview
Our Leadership
Our Board
Scientific Advisors
Collaborations
Howard Davis
CEO, Director and BoD Chairman
Richard Shen
Investor Director
Adrian Chan
Investor Director
Chris Bowden, MD
Independent Director
bottom of page
![3+-+CIC+Concierge+and+Lobby+at+245+Main this one[10].jpg](https://static.wixstatic.com/media/48870f_cb92ffa2f9904ba381c1c5ddf9bc5ddf~mv2.jpg/v1/fill/w_441,h_294,al_c,q_80,usm_0.66_1.00_0.01,enc_avif,quality_auto/48870f_cb92ffa2f9904ba381c1c5ddf9bc5ddf~mv2.jpg)
